Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TOWA Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was 円49,132 Mil.
TOWA Pharmaceutical Co's quarterly raw materials
increased
from Sep. 2025 (円47,605 Mil) to Dec. 2025 (円50,165 Mil) but then
declined
from Dec. 2025 (円50,165 Mil) to Mar. 2026 (円49,132 Mil).
TOWA Pharmaceutical Co's annual raw materials
increased
from Mar. 2024 (円38,180 Mil) to Mar. 2025 (円44,869 Mil) and
increased
from Mar. 2025 (円44,869 Mil) to Mar. 2026 (円49,132 Mil).
TOWA Pharmaceutical Co Inventories, Raw Materials & Components Historical Data
* Premium members only.
The historical data trend for TOWA Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TOWA Pharmaceutical Co Inventories, Raw Materials & Components Chart
What does a Inventories, Raw Materials & Components of 円49,132 Mil mean?
TOWA Pharmaceutical Co (TSE:4553) has a Inventories, Raw Materials & Components of 円49,132 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Inventories, Raw Materials & Components too high?
TOWA Pharmaceutical Co's current Inventories, Raw Materials & Components is 円49,132 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Inventories, Raw Materials & Components compare to ZTS?
TOWA Pharmaceutical Co's Inventories, Raw Materials & Components of 円49,132 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Inventories, Raw Materials & Components is 円49,132 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co (TSE:4553) is currently considered Modestly Overvalued. The stock's GF Value™ is 円3,389.47, compared to a current price of 円4,145.00 — trading 22.3% above its estimated fair value. The current Inventories, Raw Materials & Components is 円49,132 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 87/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TSE:4553), the current Inventories, Raw Materials & Components is 円49,132 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TOWA Pharmaceutical Co (TSE:4553) Overvalued in 2026?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円4,145.00 is trading 22.3% above its estimated GF Value™ of 円3,389.47.
GuruFocus considers TOWA Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4553:
Inventories, Raw Materials & Components: 円49,132 Mil
GF Value™: 円3,389.47 vs. price of 円4,145.00 (22.3% above fair value)
No single metric tells the full story. See the TSE:4553 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
87GF Score
Get the complete analysis for TSE:4553
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4553 has been successfully added to your 
